Cargando…

P135 SARS-COV-2 infection in patients with cystic fibrosis

Detalles Bibliográficos
Autores principales:	Balanetchi, L., Gudumac, E., Rotaru-Cojocari, D., Selevestru, R., Sciuca, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2021
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192157/ http://dx.doi.org/10.1016/S1569-1993(21)01161-9

Ejemplares similares

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry
por: Cheng, S., et al.
Publicado: (2022)

159: Lung function changes following Sars-CoV-2 infection in cystic fibrosis
por: Kremer, T., et al.
Publicado: (2021)

P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study
por: McClenaghan, E., et al.
Publicado: (2021)

P072 SARS-CoV-2 infection in patients with cystic fibrosis (CF) - a single centre experience
por: Vidoevska, A., et al.
Publicado: (2022)

P084 The impact of the SARS-CoV-2 pandemic on people living with cystic fibrosis in Ireland: real-world data from the Irish cystic fibrosis registry
por: Rees, H., et al.
Publicado: (2021)

25: Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis
por: Hergenroeder, G., et al.
Publicado: (2021)

P214 Clinical course of SARS-CoV-2 infections of paediatric patients with cystic fibrosis– a single retrospective centre experience
por: Sieber, J., et al.
Publicado: (2023)

385 Mechanisms by which cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection
por: Tedbury, P., et al.
Publicado: (2022)

382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins
por: Recchiuti, A., et al.
Publicado: (2021)

509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis
por: Bezzerri, V., et al.
Publicado: (2022)

P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group
por: Colombo, C., et al.
Publicado: (2021)

27 Effect of SARS-CoV-2 on long-term physical and mental health symptoms in people with cystic fibrosis and their caregivers
por: Hudock, K., et al.
Publicado: (2022)

P089 Coronavirus infection (COVID–19) in children with cystic fibrosis of the Russian Federation
por: Kondratyeva, E., et al.
Publicado: (2021)

P136 Relationship between cystic fibrosis disease severity and susceptibility to COVID-19 infection
por: Atalay, M., et al.
Publicado: (2021)

433 Differential small ribonucleic acid expression analysis reveals transforming growth factor beta role in SARS-CoV-2 infection of the cystic fibrosis airway
por: Hejenkowska, E., et al.
Publicado: (2022)

490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study
por: Blanchard, A., et al.
Publicado: (2021)

439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells
por: Sorio, C., et al.
Publicado: (2022)

P231 Patient experience of accessing a virtual cystic fibrosis service during the 2020 SARS-CoV-2 pandemic in Blackpool, North West of England
por: Sanderson-Thomas, A., et al.
Publicado: (2021)

343: Impact of the SARS-CoV-2 pandemic and a food pantry on food insecurity in a pediatric cystic fibrosis center
por: Holzum, H., et al.
Publicado: (2021)

485 Chronic sequelae of SARS-CoV-2 in the Scnn1b-Tg mouse model of cystic fibrosis lung disease
por: Hawkins, P., et al.
Publicado: (2022)

235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center
por: Elson, E., et al.
Publicado: (2021)

P095 Effect of age and genotype on lung function in children with cystic fibrosis
por: Shadrina, V., et al.
Publicado: (2021)

P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre
por: Warnock, L., et al.
Publicado: (2021)

P232 The impact of COVID-19 on the relationships between parents of young people diagnosed with cystic fibrosis and the cystic fibrosis multidisciplinary team
por: Jones, S., et al.
Publicado: (2021)

P146 COVID-19 pandemic in the Belgian cystic fibrosis patients compared with the international cystic fibrosis patients and the general Belgian population
por: Daneau, G., et al.
Publicado: (2023)

SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
por: Fainardi, Valentina, et al.
Publicado: (2020)

433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
por: Hernandez, R., et al.
Publicado: (2021)

P094 Facilitating cystic fibrosis research during the COVID-19 pandemic
por: Burnett, S., et al.
Publicado: (2021)

532 Humoral and cell-mediated responses to BNT162b2 mRNA vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Daccò, V., et al.
Publicado: (2022)

P075 COVID-19 vaccination uptake in patients with cystic fibrosis
por: Manning, D.-E., et al.
Publicado: (2022)

P124 Vaccination situation against COVID-19 in an adults cystic fibrosis center in Argentina
por: Baran, E., et al.
Publicado: (2023)

P175 Extended incubation of cystic fibrosis cultures: is it worth it?
por: Amado, R., et al.
Publicado: (2019)

P088 Impact of COVID-19 and cocooning on employment of people with cystic fibrosis
por: Bhatnagar, R., et al.
Publicado: (2021)

P078 Adverse effects of Kaftrio® in an adult cystic fibrosis clinic
por: McCabe, D.
Publicado: (2022)

P086 The impact of COVID-19 in people with cystic fibrosis – a single-centre experience
por: Aldous, G., et al.
Publicado: (2021)

P091 Regularity of check-ups at the cystic fibrosis centre in the time of COVID-19 pandemic
por: Todorić, I., et al.
Publicado: (2021)

P054 Severity of COVID-19 infection in cystic fibrosis patients compared to the general population
por: Rosazza, C., et al.
Publicado: (2022)

P087 Impact of COVID-19 on mental health of children with cystic fibrosis and their parents
por: Bhatnagar, R., et al.
Publicado: (2021)

P228 Concerns for people with cystic fibrosis when travelling pre-COVID-19
por: O'Doherty, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iigv7na0ngcsl42pgupdfatni5